免疫微环境塑造慢性淋巴细胞白血病的转录与遗传异质性
该研究对34例慢性淋巴细胞白血病(CLL)患者配对的外周血与淋巴结样本进行转录组分析,发现淋巴结中致癌过程上调,单细胞测序识别出静息、活化、增殖三种细胞状态,活化亚群仅占淋巴结肿瘤 bulk 的2.2%至4.3%,其10基因特征与较差的无治疗生存相关,且淋巴结T细胞炎症微环境与克隆稳定性相关。
要点
- 淋巴结中致癌过程较外周血上调,IGHV未突变者较突变者上调。
- 活化肿瘤亚群仅占淋巴结肿瘤 bulk 的2.2%至4.3%,其10基因特征与较差的无治疗生存相关。
- 淋巴结T细胞炎症微环境与克隆稳定性相关。
核心结论
- 淋巴结中一个独特的微小肿瘤亚群驱动CLL发病并影响临床结局,克隆演化轨迹受淋巴结微环境塑造,其中T细胞免疫可能有助于抑制克隆扩增。
研究设计与样本
- 研究整合了34例CLL患者配对的外周血与淋巴结样本的bulk转录组分析,并进行了单细胞RNA测序、RNA速度分析、全外显子测序及AICDA表达比较,临床试验注册号为NCT00923507。
主要发现
- 淋巴结较外周血、IGHV未突变较突变病例中致癌过程上调。
- 单细胞RNA测序区分出静息、活化、增殖三种主要细胞状态,活化亚群仅占淋巴结样本总肿瘤bulk的2.2%至4.3%。
- RNA速度分析显示淋巴结中CLL细胞命运是单向的,从增殖状态开始,过渡到活化状态,终止于静息状态。
- 源自活化肿瘤细胞的10基因特征与较差的无治疗生存相关,并与淋巴结中活化CD4+记忆T细胞和M2巨噬细胞比例正相关。
- 配对PB和LN样本的全外显子测序显示约一半患者淋巴结中存在亚克隆扩增,有或无克隆演化的病例间AICDA表达无差异,而淋巴结中T细胞炎症微环境的存在与克隆稳定性相关。
关键数值与推荐
- 活化亚群占淋巴结样本总肿瘤bulk的2.2%至4.3%。
- 10基因特征与较差的无治疗生存相关,并与淋巴结中活化CD4+记忆T细胞和M2巨噬细胞比例正相关。
- 约一半患者淋巴结中显示亚克隆扩增,有或无克隆演化的病例间AICDA表达无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In chronic lymphocytic leukemia (CLL), B-cell receptor signaling, tumor-microenvironment interactions, and somatic mutations drive disease progression. To better understand the intersection between the microenvironment and molecular events in CLL pathogenesis, we integrated bulk transcriptome profiling of paired peripheral blood (PB) and lymph node (LN) samples from 34 patients. Oncogenic processes were upregulated in LN compared with PB and in immunoglobulin heavy-chain variable (IGHV) region unmutated compared with mutated cases. Single-cell RNA sequencing (scRNA-seq) distinguished 3 major cell states: quiescent, activated, and proliferating. The activated subpopulation comprised only 2.2% to 4.3% of the total tumor bulk in LN samples. RNA velocity analysis found that CLL cell fate in LN is unidirectional, starts in the proliferating state, transitions to the activated state, and ends in the quiescent state. A 10-gene signature derived from activated tumor cells was associated with inferior treatment-free survival (TFS) and positively correlated with the proportion of activated CD4+ memory T cells and M2 macrophages in LN. Whole exome sequencing (WES) of paired PB and LN samples showed subclonal expansion in LN in approximately half of the patients. Since mouse models have implicated activation-induced cytidine deaminase in mutagenesis, we compared AICDA expression between cases with and without clonal evolution but did not find a difference. In contrast, the presence of a T-cell inflamed microenvironment in LN was associated with clonal stability. In summary, a distinct minor tumor subpopulation underlies CLL pathogenesis and drives the clinical outcome. Clonal trajectories are shaped by the LN milieu, where T-cell immunity may contribute to suppressing clonal outgrowth. The clinical study is registered at clinicaltrials.gov as NCT00923507.
引用
- Sun C, Chen YC, Martinez Zurita A, et al. The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia. Blood Adv. 2023. PMID: 35358998. doi:10.1182/bloodadvances.2021006941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。